LEXICON PHARMACEUTICALS, INC. (LXRX) Operating cash flow 2016–2025
LEXICON PHARMACEUTICALS, INC. (LXRX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$67.9MFY2025 · since FY2016: -$175.6M → -$67.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$67.9M | +62.0% |
| FY2024 | -$178.8M | -10.4% |
| FY2023 | -$161.9M | -82.2% |
| FY2022 | -$88.9M | -2.1% |
| FY2021 | -$87.0M | +39.1% |
| FY2020 | -$143.0M | -225.6% |
| FY2019 | $113.8M | +176.6% |
| FY2018 | -$148.6M | +19.8% |
| FY2017 | -$185.4M | -5.6% |
| FY2016 | -$175.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More LXRX financial trends
LXRX RevenueLXRX Net incomeLXRX Net marginLXRX Gross profitLXRX Gross marginLXRX Operating incomeLXRX Operating marginLXRX Free cash flowLXRX Capital expendituresLXRX Return on equityLXRX Stock buybacksLXRX Dividends paidLXRX Total assetsLXRX Total liabilitiesLXRX Shareholders’ equityLXRX overview →